Skip to content. | Skip to navigation

Personal tools

Julie Nielsen, PhD

Peer-Reviewed Papers


  • Wick DA, Webb JR, Nielsen JS, Martin SD, Kroeger DR, Milne K, Castellarin M,Twumasi-Boateng K, Watson PH, Holt RA, Nelson BH. Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer. Clin Cancer Res. 2014 Mar 1;20(5):1125-34. doi: 10.1158/1078-0432.CCR-13-2147.Epub 2013 Dec 9. [PubMed - 24323902]


    • Nielsen,J.S, Sahota, R.A, Milne, K.,Kost, S.E., Nesslinger, N.J., Watson, P.H., Nelson, B.H. 2012. CD20+ tumour-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. Clin Cancer Res. Jun 15. 18(12):3281-92. [PubMed - 22553348]
    • Nielsen, J.S and Nelson, B.H.2012 Tumor-infiltrating B Cells and T Cells: working together to promote patient survival. Oncoimmunology. 2012 Dec 1;1(9):1623-1625. [PubMed - 23264915]



    • Salzman J, Marinelli RJ, Wang PL, Green AE, Nielsen JS, Nelson BH, Drescher CW, Brown PO. ESRRA-C11orf20 Is a Recurrent Gene Fusion in Serous Ovarian Carcinoma. PLoS Biol. 2011 Sep;9(9):e1001156. Epub 2011 Sep 20. [PubMed - 21949640]



    • Tran E, Nielsen JS, Wick DA, Ng AV, Johnson LD, Nesslinger NJ, McMurtrie E, Webb JR, Nelson BH.  Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines. PLoS ONE 5(12): e15625 (Dec 2010). [PubMed - 21203522]

    • Nielsen JS, Wick DA, Tran E, Nelson BH, Webb JR. An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies. J Immunol Methods. 2010 Jul 15. [Epub ahead of print] [PubMed - 20637775]

    • Webb JR, Wick DA, Nielsen JS, Tran E, Milne K, McMurtrue E, Nelson BH.  Profound elevation of CD8(+) T cells expressing the intraepithelial lymphocyte marker CD103 (alpha(E)/beta(7) Integrin) in high-grade serous ovarian cancer. Gynecol Oncol. 2010 Jun 9 [Epub ahead of print] [PubMed - 20541243] Related citations



    • Nielsen JS, McNagny KM. The role of podocalyxin in health and disease. J Am Soc Nephrol. 20(8):1669-76 (2009). [PubMed - 19578008] 
    • Nielsen JS, McNagny KM. CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery. Microcirculation. 16(6):487-96 (2009)[PubMed - 19479621] 
    • Yang T, *Martin ML, *Nielsen JS, Milne K, Wall EM, Lin W, Watson PH, Nelson BH. Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the Cbl-b gene. (*co-second authors) Cancer Immunol Immunother. 58(11):1865-75 (2009). [PubMed - 19350239]



    • Milne K, Barnes RO, Girardin A, Mawer MA, Nesslinger NJ, Ng A, Nielsen JS, Sahota R, Tran E, Webb JR, Wong MQ, Wick DA, Wray A, McMurtrie E, Kobel M, Kalloger SE, Gilks CB, Watson PH, Nelson BH. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer PLoS ONE 3(10): e3409 (2008)[PubMed - 18923710]
    • Nielsen JS, McNagny KM. Novel functions of the CD34 family J Cell Sci 121(22): 3683-92 (2008)[PubMed - 18987355]



    • Nielsen JS, Graves ML, Chelliah S, Vogl AW, Roskelley CD, McNagny KM. The CD34-related molecule podocalyxin is a potent inducer of microvillus formation. PLoS ONE 2(2): e237 (2007)[PubMed - 17311105]
    • Nielsen JS, McNagny KM. Influence of host irradiation on long-term engraftment by CD34-deficient hematopoietic stem cells. Blood 110(3): 1076-7 (2007). [PubMed - 17644746]



    • Doyonnas R, *Nielsen JS, Chelliah S, Drew E, Hara T, Miyajima A, McNagny KM. Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells. (*co-first authors) Blood 105(11): 4170-8 (2005). [PubMed - 15701716]



    • Somasiri A, Nielsen JS, Makretsov N, McCoy ML, Prentice L, Gilks CB, Chia SK, Gelmon KA, Kershaw DB, Huntsman DG, McNagny KM, Roskelley CD. Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res. 64(15): 5068-73 (2004). [PubMed - 15289306]



    • Nielsen JS, Doyonnas R, McNagny KM. Avian models to study the transcriptional control of hematopoietic lineage commitment and to identify lineage-specific genes. Cells Tissues Organs 171(1): 44-63 (2002)[PubMed - 12021491]